Chile on Wednesday became the latest country to give emergency approval to China’s CoronaVac vaccine…
View More Chile approves Chinese coronavirus vaccine
Canada approves Pfizer-BioNTech Covid-19 vaccine
Canada on Wednesday approved the Pfizer-BioNTech COVID-19 vaccine, days after Britain became the first country…
View More Canada approves Pfizer-BioNTech Covid-19 vaccine
FDA approves drug for PET imaging of prostate cancer
(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET)…
View More FDA approves drug for PET imaging of prostate cancer
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
HOUSTON, Dec. 1, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a…
View More Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)
TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that…
View More FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)
White House approves tougher rules for COVID-19 vaccine development
(HealthDay)—Following weeks of delay, the White House on Tuesday approved tough new rules for COVID-19…
View More White House approves tougher rules for COVID-19 vaccine development
White House Approves Tougher Rules for COVID-19 Vaccine Development
WEDNESDAY, Oct. 7, 2020 — Following weeks of delay, the White House on Tuesday approved…
View More White House Approves Tougher Rules for COVID-19 Vaccine Development
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that…
View More FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
FDA approves first contact lens that slows myopia progression
(HealthDay)—MiSight, the first contact lens indicated to slow the progression of myopia in children ages…
View More FDA approves first contact lens that slows myopia progression
FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
SAN DIEGO, Feb. 26, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology…
View More FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push